BlackRock launches iShares US biotech ETF

TER of 0.35%

Tom Eckett
@TomEckettIW
26 October 2017

Tweet
Facebook
LinkedIn
Share on Whatsapp
Send to

BlackRock has launched the iShares Nasdaq US Biotechnology UCITS ETF investing directly in biotech and pharmaceutical stocks which are listed on the Nasdaq stock exchange.

Listed on the London Stock Exchange on 23 October, the ETF has a total expense ratio (TER) of 0.35% and will track the Nasdaq Biotechnology index. The index, which has 161 stocks, is calculated using...

To continue reading...

Register Now

Investment Week helps enlightened investment professionals to grow revenues and manage risk by reading the market more astutely via this industry leading title.

Investment Week offers:-

REAL-TIME NEWS & ANALYSIS: find out what's happening in the market right now and why. Understand key asset classes and opportunities for new business
DISRUPTION: learn how technological developments and regulatory change will shape your decisions
OPINION: incisive, useful and provocative insights from experts